|
CA2656679A1
|
|
Use of ginseng fractions for preventing or reducing hematological malignancies
|
|
US6593340B1
|
|
Pharmaceutical compositions containing N-propargylphentermine and related analogs to treat neurodegeneration and/or depression
|
|
AU4136600A
|
|
Water extract of chamomile, process for obtaining it and use as an antifungal agent
|
|
AU3478600A
|
|
Treatment of autoimmune diseases with american ginseng extract
|
|
CN1308492A
|
|
Hypericin and i(hypericum) extract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeutics
|
|
CA2314453A1
|
|
Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
|
|
CN1268027A
|
|
Chemical and pharmacological standardization of herbal extracts
|
|
CN1263534A
|
|
A preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
|
|
US6083932A
|
|
Pharmaceutical compositions derived from ginseng and methods of treatment using same
|
|
US6060516A
|
|
N1 -propargylhydrazines, N2 -propargylhydrazines and their analogs for the treatment of depression, anxiety and neurodegeneration
|
